Dr. K. Narayanan Menon

Sumeet Asrani, MD, MSc is the Chief of Hepatology and Liver Transplantation at the Baylor Simmons Transplant Institute in Dallas. He has served as the Medical Director of the Center for Advanced Liver Disease since 2016. He provides clinical care at Baylor University Medical Center (BUMC) and Baylor Scott and White Medical Center – Waxahachie. Recently, Dr. Asrani has restructured the research enterprise of the Simmons Transplant Institute and has been instrumental in elevating the name of the Institute and Baylor Scott & White as a recognized presence in the national and international academic world. Dr. Asrani received his medical degree from Baylor College of Medicine in Houston. He did his internship and residency at Washington University School of Medicine in St. Louis, MO. He went on to complete fellowships in gastroenterology, hepatology and transplant hepatology at the Mayo Clinic in Rochester, Minnesota before joining the transplant hepatology team at Baylor University Medical Center in 2013. Dr. Asrani has published 140 peer review publications, 300 abstracts and given over 125 national and international presentations. In addition, he has mentored more than 30 trainees to help advance their medical careers. Dr. Asrani previously served as an associate editor for the American Journal of Transplantation (AJT) and as an associate editor for Liver Transplantation (LT). He is actively involved in national and international collaborations to improve care for patients with liver disease. Dr. Asrani specializes in the management of patients with end-stage liver disease, liver transplantation candidates and recipients. His other clinical interests include liver cancer, viral hepatitis, autoimmune hepatitis, primary sclerosing cholangitis and alcohol associated liver disease. His research interests focus on early identification of patients with cirrhosis, improving quality of patients with liver disease especially in the rural setting, improving kidney function in patients with liver disease and organ allocation. In his free time, Dr, Asrani enjoys various fitness endeavors, playing the drums, and traveling with his wife and four children. Dr. Asrani was recognized by D Magazine as a Best Doctor for 2023, 2024 and 2025. Dr. Asrani is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Liver Failure, Ascites, Hepatitis, Liver Transplant, and Kidney Transplant. Dr. Asrani is board certified in Gastroenterology- American Board Of Internal Medicine, Transplant Hepatology- American Board Of Internal Med/Transplant Hepatology, Transplant Hepatology- American Board Of Internal Medicine, and Gastroenterology- American Board Of Internal Med/Gastroenterology. Dr. Asrani is currently accepting new patients.

"Dr. Rahimi is board certified in transplant hepatatology, gastroenterology and internal medicine. His clinical interests include chronic liver disease, liver cancer, liver failure, metabolic and autoimmune diseases of the liver, viral hepatitis, complications of cirrhosis and liver transplantation. Dr. Rahimi has authored several research articles on improving the outcomes of patients with advanced liver disease. Dr. Rahimi holds a Master of Science in Applied Physiology from Finch University of Health Sciences in North Chicago and medical degree from Chicago Medical School. While completing his internship and residency in Internal Medicine at the University of Virginia in Charlottesville, VA, he concurrently obtained a Master of Science in Clinical Research in the Department of Public Health. Upon relocating to Dallas, Dr. Rahimi completed two fellowships, the first in Gastroenterology at the University of Texas Southwestern Medical Center followed by a fellowship in Transplant Hepatology at Baylor University Medical Center, part of Baylor Scott & White Health, in Dallas. Read more about Dr. Rahimi’s publications on PubMed.gov and the Baylor Health Sciences Library . Read Dr. Rahimi's article, ""5 things you need to know about fatty liver disease (and how to reverse it)"" . Dr. Rahimi is involved in a study around the use of statins in patients with advanced liver failure and cirrhosis. Read more here . Dr. Rahimi was recognized by D Magazine as a Best Doctor for 2024 and 2025. Read Dr. Rahimi's article, ""Can fatty liver be reversed? 5 common questions, answered.""". Dr. Rahimi is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Liver Failure, Esophageal Varices, Ascites, Liver Transplant, and Hepato-Pancreato-Biliary Surgery. Dr. Rahimi is board certified in Gastroenterology- American Board Of Internal Medicine, Transplant Hepatology- American Board Of Internal Med/Transplant Hepatology, Transplant Hepatology- American Board Of Internal Medicine, and Gastroenterology- American Board Of Internal Med/Gastroenterology. Dr. Rahimi is currently accepting new patients.

"Dr. Liza Johannesson, M.D., Ph.D., is a graduate of the Karolinska Institute, Sweden. She completed training in Obstetrics and Gynecology at the Sahlgrenska University Hospital, Sweden, followed by training in gynecologic oncology at Sahlgrenska University Hospital and Royal Adelaide Hospital, Australia. She presented her PhD thesis about Uterus Transplantation in primates in 2012 and was a pivotal part of the world pioneering first clinical human trial of Uterus Transplantation in Sweden that resulted in the first birth after Uterus Transplantation in the world. She was recruited by Baylor University Medical Center in 2017 to build up a new Uterus Transplant Program. The program resulted in the first birth after Uterus Transplant in the US in 2017 and is today the largest and most successful Uterus Transplant program in the world. Dr. Johannesson serves as the Medical Director of Uterus Transplantation and is an Associate Professor of Surgery at Texas A&M College of Medicine at Texas A&M Health Science Center, Dallas. Dr. Johannesson is actively involved in the US Uterus Transplant Consortium (USUTC), the American Society of Transplant Surgeons (ASTS), the Vascular Composite Allograft Committee, in the United Network for Organ Sharing (UNOS), the Vascular Composite Allograft Committee and of the genitourinary workgroup, in the American Society of Reconstructive Transplantation (ASRT), and in the American Society for Reproductive Medicine (ASRM). She is a Founding Member of both the International Society of Uterus Transplantation (ISUTX) and the USUTC. Dr. Johannesson is an active researcher with more than 100 publications and is invited to lecture worldwide on current issues in the field of Uterus Transplantation. Dr.  Johannesson was recently featured in D Magazine's ""The Best Doctors 2025, The Women's Health Issue."" Read the article ""Uterus Transplants Offer a New Path to Motherhood"" as she discusses their groundbreaking team. Baylor Scott & White’s program was the first in the United States to have a live birth after a uterine transplant, and it was the first in the world to perform a uterus transplant outside of a clinical trial. As of August 2024, Baylor has performed 33 uterus transplant surgeries, resulting in 22 live births. To date, they have received interest from donors in 41 states, which is about triple the 10 to 15 cases per year that they can complete.". Dr. Johannesson is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Infertility, Mayer-Rokitansky-Kuster-Hauser Syndrome, Kuster Syndrome, Hysterectomy, and Kidney Transplant. Dr. Johannesson is currently accepting new patients.